CoChat
Sign Up
Cited by 153

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer

Hu, Danrong, Li, Yicong, Li, Ran, Wang, Meng, Zhou, Kai, He, Chengqi, Wei, Quan, Qian, Zhiyong·2024·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2024.10.015PMC PMC11725102
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.apsb.2024.10.015

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 301

  1. Siegel, 2024, Cancer statistics, 2024, Ca-Cancer J Clin, 74, 12, 10.3322/caac.21820 · DOI · Paper page
  2. Jiang, 2023, Drug-induced oxidative stress in cancer treatments: angel or devil?, Redox Biol, 63, 10.1016/j.redox.2023.102754 · DOI
  3. Beckers, 2024, Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities, Semin Cancer Biol, 98, 19, 10.1016/j.semcancer.2023.11.006 · DOI
  4. Qu, 2023, Cancer nanomedicine in preoperative therapeutics: nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy, Bioact Mater, 24, 136
  5. Wang, 2024, Small-molecule agents for cancer immunotherapy, Acta Pharm Sin B, 14, 905, 10.1016/j.apsb.2023.12.010 · DOI
  6. Lin, 2024, Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy, Acta Pharm Sin B, 14, 854, 10.1016/j.apsb.2023.08.014 · DOI
  7. Overchuk, 2023, Photodynamic and photothermal therapies: synergy opportunities for nanomedicine, Acs Nano, 17, 7979, 10.1021/acsnano.3c00891 · DOI
  8. Li, 2020, Clinical development and potential of photothermal and photodynamic therapies for cancer, Nat Rev Clin Oncol, 17, 657, 10.1038/s41571-020-0410-2 · DOI · Paper page
  9. Jiang, 2022, Tumor microenvironment-responsive MnSiO3-Pt@BSA-Ce6 nanoplatform for synergistic catalysis-enhanced sonodynamic and chemodynamic cancer therapy, Chin Chem Lett, 33, 2959, 10.1016/j.cclet.2021.12.096 · DOI
  10. Huang, 2021, Photodynamic therapy for hypoxic tumors: advances and perspectives, Coord Chem Rev, 438, 10.1016/j.ccr.2021.213888 · DOI
  11. Li, 2023, Emerging nanotherapeutics for facilitating photodynamic therapy, Chem Eng J, 451
  12. Hu, 2021, Trimodal sono/photoinduced focal therapy for localized prostate cancer: single-drug-based nanosensitizer under dual-activation, Adv Funct Mater, 31
  13. Tu, 2023, Engineered metallacycle-based supramolecular photosensitizers for effective photodynamic therapy, Angew Chem Int Edit, 62, 10.1002/anie.202301560 · DOI
  14. Li, 2022, Near-infrared light and redox dual-activatable nanosystems for synergistically cascaded cancer phototherapy with reduced skin photosensitization, Biomaterials, 288, 10.1016/j.biomaterials.2022.121700 · DOI
  15. Chu, 2024, Deepened photodynamic therapy through skin optical clearing technology in the visible light window, Langmuir, 40, 1007, 10.1021/acs.langmuir.3c03231 · DOI
  16. Cui, 2023, Beyond external light: on-spot light generation or light delivery for highly penetrated photodynamic therapy, Acs Nano, 17, 20776, 10.1021/acsnano.3c05619 · DOI
  17. Tang, 2024, Oxygen-independent organic photosensitizer with ultralow-power NIR photoexcitation for tumor-specific photodynamic therapy, Nat Commun, 15, 2530, 10.1038/s41467-024-46768-w · DOI
  18. Wang, 2023, Research advances in bodipy-assembled supramolecular photosensitizers for photodynamic therapy, Coordin Chem Rev, 496, 10.1016/j.ccr.2023.215367 · DOI
  19. Dirak, 2024, Recent advances in organelle-targeted organic photosensitizers for efficient photodynamic therapy, Coordin Chem Rev, 506, 10.1016/j.ccr.2024.215710 · DOI
  20. Liu, 2023, Emodin-based nanoarchitectonics with giant two-photon absorption for enhanced photodynamic therapy, Angew Chem Int Edit, 62
  21. Hu, 2020, Application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia, View, 1, e6, 10.1002/viw2.6 · DOI
  22. Yi, 2023, Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials, Eur J Med Chem, 247, 10.1016/j.ejmech.2022.115084 · DOI
  23. Yin, 2023, Light-triggered photosynthetic engineered bacteria for enhanced-photodynamic therapy by relieving tumor hypoxic microenvironment, Theranostics, 13, 1632, 10.7150/thno.81718 · DOI
  24. Li, 2023, Innovative strategies for photodynamic therapy against hypoxic tumor, Asian J Pharm Sci, 18
  25. Zhang, 2024, Immune cells: potential carriers or agents for drug delivery to the central nervous system, Mil Med Res, 11, 19
  26. Peng, 2021, Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy, Acta Pharm Sin B, 11, 1069, 10.1016/j.apsb.2020.06.013 · DOI
  27. He, 2024, Recent progress in implantable drug delivery systems, Adv Mater, 36
  28. Zeng, 2023, Advancements in nanoparticle-based treatment approaches for skin cancer therapy, Mol Cancer, 22, 10, 10.1186/s12943-022-01708-4 · DOI
  29. Pramanik, 2024, Recent advances in drug delivery and targeting for the treatment of pancreatic cancer, J Control Release, 366, 231, 10.1016/j.jconrel.2023.12.053 · DOI
  30. Xiang, 2022, Gold nanoparticle drug delivery system: principle and application, J Biomater Tiss Eng, 12, 445, 10.1166/jbt.2022.2934 · DOI
  31. Chen, 2024, Metal nanoparticles for cancer therapy: precision targeting of DNA damage, Acta Pharm Sin B, 14, 1132, 10.1016/j.apsb.2023.08.031 · DOI
  32. Bisen, 2024, A review on polymers in ocular drug delivery systems, Med Comm Biomater Appl, 3, e77
  33. Mikhail, 2023, Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer, Adv Drug Deliv Rev, 202, 10.1016/j.addr.2023.115083 · DOI
  34. Shi, 2023, Recent progresses of collagen dressings for chronic skin wound healing, Collagen Leather, 5, 31, 10.1186/s42825-023-00136-4 · DOI
  35. Li, 2023, Hollow nanomaterials in advanced drug delivery systems: from single to multiple shells, Adv Mater, 35
  36. Pourmadadi, 2023, Innovative nanomaterials for cancer diagnosis, imaging, and therapy: drug delivery applications, J Drug Deliv Sci Tec, 82
  37. Erfani, 2023, Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment, Mater Today, 65, 227, 10.1016/j.mattod.2023.03.006 · DOI
  38. Liu, 2023, pH-responsive dual-functional hydrogel integrating localized delivery and anti-cancer activities for highly effective therapy in PDX of OSCC, Mater Today, 62, 71, 10.1016/j.mattod.2022.12.009 · DOI
  39. Chen, 2023, Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease, Adv Drug Deliver Rev, 203, 10.1016/j.addr.2023.115117 · DOI
  40. Zhu, 2024, Platelet-derived drug delivery systems: pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond, Biomaterials, 306, 10.1016/j.biomaterials.2024.122478 · DOI
  41. Yang, 2022, Hybrid lipid nanoparticles loaded with doxorubicin for the therapy of breast cancer, J Biomater Tiss Eng, 12, 2175, 10.1166/jbt.2022.3157 · DOI
  42. Wang, 2022, Dendrimer-based drug delivery systems: history, challenges, and latest developments, J Biol Eng, 16, 18, 10.1186/s13036-022-00298-5 · DOI
  43. Li, 2023, Nanotechnology connecting copper metabolism and tumor therapy, Med Comm Biomater Appl, 2
  44. Sun, 2023, Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments, Adv Drug Deliver Rev, 196, 10.1016/j.addr.2023.114773 · DOI
  45. Zhang, 2023, Stimuli-responsive gene delivery nanocarriers for cancer therapy, Nano-Micro Lett, 15, 44, 10.1007/s40820-023-01018-4 · DOI
  46. Jing, 2022, The intracellular and extracellular microenvironment of tumor site: the trigger of stimuli-responsive drug delivery systems, Small Methods, 6, 10.1002/smtd.202101437 · DOI
  47. Su, 2024, Precise tumor treatment: pH-responsive nanoparticles for modulating and real-time monitoring tumor microenvironment, Med Comm Biomater Appl, 3
  48. Wan, 2023, Intracellular and extracellular enzymatic responsive micelle for intelligent therapy of cancer, Nano Res, 16, 2851, 10.1007/s12274-022-4967-1 · DOI
  49. Zhang, 2023, An MMP-2 sensitive and reduction-responsive prodrug amphiphile for actively targeted therapy of cancer by hierarchical cleavage, Chem Commun, 59, 900, 10.1039/D2CC05586D · DOI
  50. Ballance, 2019, Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases, Biomaterials, 217, 10.1016/j.biomaterials.2019.119292 · DOI
  51. Wang, 2021, ROS-responsive amphiphilic block copolymer-drug conjugate: design, synthesis and potential as an efficient drug delivery system via a positive feedback strategy, Chem Eng J, 425, 10.1016/j.cej.2021.131453 · DOI
  52. Yang, 2020, Recent advances in tumor microenvironment hydrogen peroxide-responsive materials for cancer photodynamic therapy, Nano-Micro Lett, 12, 15, 10.1007/s40820-019-0347-0 · DOI
  53. Wang, 2023, Targeting self-enhanced ROS-responsive artesunatum prodrug nanoassembly potentiates gemcitabine activity by down-regulating CDA expression in cervical cancer, Chin Chem Lett, 34
  54. Yang, 2022, Recent advances in redox-responsive nanoparticles for combined cancer therapy, Nanoscale Adv, 4, 3504, 10.1039/D2NA00222A · DOI
  55. Hu, 2019, Perfluorocarbon-loaded and redox-activatable photosensitizing agent with oxygen supply for enhancement of fluorescence/photoacoustic imaging guided tumor photodynamic therapy, Adv Funct Mater, 29, 10.1002/adfm.201806199 · DOI
  56. Gao, 2022, Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy, Acta Biomater, 147, 299, 10.1016/j.actbio.2022.05.046 · DOI
  57. He, 2023, Redox-responsive phenyl-functionalized polylactide micelles for enhancing Ru complexes delivery and phototherapy, Chin Chem Lett, 34, 10.1016/j.cclet.2022.05.088 · DOI
  58. Yang, 2022, Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy, Acta Pharm Sin B, 12, 2710, 10.1016/j.apsb.2021.08.021 · DOI
  59. Hu, 2023, Hypoxia-responsive host–guest drug delivery system, Acc Mater, 4, 925, 10.1021/accountsmr.3c00130 · DOI
  60. Guo, 2023, Dual hypoxia-responsive supramolecular complex for cancer target therapy, Nat Commun, 14, 5634, 10.1038/s41467-023-41388-2 · DOI
  61. Tang, 2023, Hypoxia-responsive photosensitizer targeting dual organelles for photodynamic therapy of tumors, Small, 19
  62. Son, 2019, Light-responsive nanomedicine for biophotonic imaging and targeted therapy, Adv Drug Deliv Rev, 138, 133, 10.1016/j.addr.2018.10.002 · DOI
  63. Shi, 2022, Dual light-responsive cellulose nanofibril-based in situ hydrogel for drug-resistant bacteria infected wound healing, Carbohyd Polym, 297, 10.1016/j.carbpol.2022.120042 · DOI
  64. Xue, 2023, Advances of NIR light responsive materials for diagnosis and treatment of brain diseases, Adv Opt Mater, 11, 10.1002/adom.202202888 · DOI
  65. Lu, 2022, Near infrared light (NIR)-responsive nanoliposomes combining photodynamic therapy and chemotherapy for breast tumor control, Chin Chem Lett, 33, 1923, 10.1016/j.cclet.2021.11.039 · DOI
  66. Huang, 2023, Ultrasound-responsive matters for biomedical applications, Innovation, 4
  67. Sun, 2022, Ultrasound-responsive peptide nanogels to balance conflicting requirements for deep tumor penetration and prolonged blood circulation, Acs Nano, 16, 9183, 10.1021/acsnano.2c01407 · DOI
  68. Xiu, 2023, Ultrasound-responsive catalytic microbubbles enhance biofilm elimination and immune activation to treat chronic lung infections, Sci Adv, 9, 10.1126/sciadv.ade5446 · DOI
  69. Ruan, 2022, Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer, Bioact Mater, 13, 191
  70. Wang, 2023, Enhanced chemo-immunotherapy strategy utilizing injectable thermosensitive hydrogel for the treatment of diffuse peritoneal metastasis in advanced colorectal cancer, Adv Sci, 10, 10.1002/advs.202303819 · DOI
  71. Luo, 2024, Self-powered electrically controlled drug release systems based on nanogenerator, Adv Funct Mater, 34
  72. Kolosnjaj Tabi, 2019, Electric field-responsive nanoparticles and electric fields: physical, chemical, biological mechanisms and therapeutic prospects, Adv Drug Deliver Rev, 138, 56, 10.1016/j.addr.2018.10.017 · DOI
  73. Guo, 2019, Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy, Biomaterials, 219, 10.1016/j.biomaterials.2019.119370 · DOI
  74. Cao, 2023, X-ray-responsive prodrugs and polymeric nanocarriers for multimodal cancer therapy, Chem Commun, 59, 8323, 10.1039/D3CC01398G · DOI
  75. Deng, 2018, Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation, Nat Commun, 9, 2713, 10.1038/s41467-018-05118-3 · DOI
  76. Zhang, 2020, Low-dose X-ray-responsive diselenide nanocarriers for effective delivery of anticancer agents, Acs Appl Mater Inter, 12, 43398, 10.1021/acsami.0c11627 · DOI
  77. Tao, 2023, Uniting dual-modal MRI/chemiluminescence nanotheranostics: spatially and sensitively self-reporting photodynamic therapy in oral cancer, Adv Funct Mater, 33, 10.1002/adfm.202303240 · DOI
  78. Desai, 2024, Photodynamic therapy induced mitochondrial targeting strategies for cancer treatment: emerging trends and insights, Mol Pharmaceut, 21, 1591, 10.1021/acs.molpharmaceut.3c01185 · DOI
  79. Tang, 2022, Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy, Bioact Mater, 15, 355
  80. Li, 2022, Recent advances in enhancing reactive oxygen species based chemodynamic therapy, Chin Chem Lett, 33, 2213, 10.1016/j.cclet.2021.11.048 · DOI
  81. Yang, 2023, Emerging sonodynamic therapy-based nanomedicines for cancer immunotherapy, Adv Sci, 10
  82. Pan, 2023, Newly developed gas-assisted sonodynamic therapy in cancer treatment, Acta Pharm Sin B, 13, 2926, 10.1016/j.apsb.2022.12.021 · DOI
  83. Zhang, 2023, Nano-ROS-generating approaches to cancer dynamic therapy: lessons from nanoparticles, Chem Eng J, 457, 10.1016/j.cej.2022.141225 · DOI · Paper page
  84. Di, 2023, Optimized strategies of ROS-based nanodynamic therapies for tumor theranostics, Biomaterials, 303, 10.1016/j.biomaterials.2023.122391 · DOI
  85. Sun, 2024, Natural polysaccharide-based smart CXCR4-targeted nano-system for magnified liver fibrosis therapy, Chin Chem Lett, 35, 10.1016/j.cclet.2023.108803 · DOI
  86. Cheung, 2022, The role of ROS in tumour development and progression, Nat Rev Cancer, 22, 280, 10.1038/s41568-021-00435-0 · DOI
  87. Sies, 2022, Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology, Nat Rev Mol Cell Bio, 23, 499, 10.1038/s41580-022-00456-z · DOI · Paper page
  88. Shi, 2024, Tumor microenvironment ROS/pH cascade-responsive supramolecular nanoplatform with ROS regeneration property for enhanced hepatocellular carcinoma therapy, Acs Appl Mater Inter, 16, 7576, 10.1021/acsami.3c16022 · DOI · Paper page
  89. Yang, 2019, Reactive oxygen species (ROS)-based nanomedicine, Chem Rev, 119, 4881, 10.1021/acs.chemrev.8b00626 · DOI
  90. Jiang, 2023, Overcoming oxygen heterogeneity of tumor microenvironments to boost cancer immunotherapy by oxygen-switchable ROS/RNS nanogenerators, Nano Today, 48, 10.1016/j.nantod.2022.101696 · DOI
  91. Liu, 2021, Tumor cell-activated “sustainable ROS generator” with homogeneous intratumoral distribution property for improved anti-tumor therapy, Theranostics, 11, 379, 10.7150/thno.50028 · DOI
  92. Luo, 2019, Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy, J Control Release, 302, 79, 10.1016/j.jconrel.2019.04.001 · DOI
  93. Wang, 2023, ROS-responsive self-activatable photosensitizing agent for photodynamic-immunotherapy of cancer, Acta Biomater, 164, 511, 10.1016/j.actbio.2023.03.038 · DOI
  94. Wei, 2023, Stimuli-responsive polymer-based nanosystems for cancer theranostics, Acs Nano, 17, 23223, 10.1021/acsnano.3c06019 · DOI
  95. Li, 2023, Activatable nano-photosensitizers for precise photodynamic cancer therapy, Coord Chem Rev, 493, 10.1016/j.ccr.2023.215324 · DOI
  96. Choi, 2022, Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment, Adv Drug Deliv Rev, 186, 10.1016/j.addr.2022.114344 · DOI
  97. Idelchik, 2017, Mitochondrial ROS control of cancer, Semin Cancer Biol, 47, 57, 10.1016/j.semcancer.2017.04.005 · DOI
  98. Montllor Albalate, 2022, Sod1 integrates oxygen availability to redox regulate NADPH production and the thiol redoxome, Proc Natl Acad Sci U S A, 119, 10.1073/pnas.2023328119 · DOI
  99. Islam, 2022, Superoxide dismutase: an updated review on its health benefits and industrial applications, Crit Rev Food Sci, 62, 7282, 10.1080/10408398.2021.1913400 · DOI · Paper page
  100. Bretón Romero, 2014, Hydrogen peroxide signaling in vascular endothelial cells, Redox Biol, 2, 529, 10.1016/j.redox.2014.02.005 · DOI
  101. Pisoschi, 2021, Oxidative stress mitigation by antioxidants—an overview on their chemistry and influences on health status, Eur J Med Chem, 209, 10.1016/j.ejmech.2020.112891 · DOI
  102. Zheng, 2021, The recent progress on metal-organic frameworks for phototherapy, Chem Soc Rev, 50, 5086, 10.1039/D1CS00056J · DOI
  103. Chen, 2023, Enhanced H2O2 utilization efficiency in fenton-like system for degradation of emerging contaminants: oxygen vacancy-mediated activation of O2, Water Res, 230, 10.1016/j.watres.2022.119562 · DOI
  104. Griendling, 2016, Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the american heart association, Circ Res, 119, e39, 10.1161/RES.0000000000000110 · DOI
  105. Volpe, 2018, Cellular death, reactive oxygen species (ROS) and diabetic complications, Cell Death Dis, 9, 119, 10.1038/s41419-017-0135-z · DOI
  106. Yeung, 2020, Reactive oxygen species and their impact in neurodegenerative diseases: literature landscape analysis, Antioxid Redox Sign, 34, 402, 10.1089/ars.2019.7952 · DOI
  107. Lennicke, 2021, Redox metabolism: ROS as specific molecular regulators of cell signaling and function, Mol Cell, 81, 3691, 10.1016/j.molcel.2021.08.018 · DOI
  108. Ju, 2020, NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications, Signal Transduct Tar, 5, 231, 10.1038/s41392-020-00326-0 · DOI
  109. Holmström, 2014, Cellular mechanisms and physiological consequences of redox-dependent signalling, Nat Rev Mol Cell Bio, 15, 411, 10.1038/nrm3801 · DOI · Paper page
  110. Vercellino, 2022, The assembly, regulation and function of the mitochondrial respiratory chain, Nat Rev Mol Cell Bio, 23, 141, 10.1038/s41580-021-00415-0 · DOI
  111. Vinothkumar, 2014, Architecture of mammalian respiratory complex I, Nature, 515, 80, 10.1038/nature13686 · DOI
  112. Fiedorczuk, 2016, Atomic structure of the entire mammalian mitochondrial complex I, Nature, 538, 406, 10.1038/nature19794 · DOI
  113. Shadel, 2015, Mitochondrial ROS signaling in organismal homeostasis, Cell, 163, 560, 10.1016/j.cell.2015.10.001 · DOI · Paper page
  114. Cadenas, 2018, ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection, Free Radic Bio Med, 117, 76, 10.1016/j.freeradbiomed.2018.01.024 · DOI
  115. Mazat, 2020, Modelling mitochondrial ROS production by the respiratory chain, Cell Mol Life Sci, 77, 455, 10.1007/s00018-019-03381-1 · DOI
  116. Munro, 2019, Comparative studies of mitochondrial reactive oxygen species in animal longevity: technical pitfalls and possibilities, Aging Cell, 18, 10.1111/acel.13009 · DOI
  117. Hübner, 2021, Interactions of zinc- and redox-signaling pathways, Redox Biol, 41, 10.1016/j.redox.2021.101916 · DOI
  118. Warris, 2019, Oxidative responses and fungal infection biology, Semin Cell Dev Biol, 89, 34, 10.1016/j.semcdb.2018.03.004 · DOI
  119. Koju, 2019, Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria, Biomed Pharmacother, 111, 1478, 10.1016/j.biopha.2018.11.128 · DOI
  120. Carvalho, 2022, Redox-related proteins in melanoma progression, Antioxidants-Basel, 11, 438, 10.3390/antiox11030438 · DOI
  121. Fuhrmann, 2022, A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis, Redox Biol, 54, 10.1016/j.redox.2022.102365 · DOI
  122. Vermot, 2021, NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology, Antioxidants-Basel, 10, 890, 10.3390/antiox10060890 · DOI · Paper page
  123. Begum, 2022, NADPH oxidase family proteins: signaling dynamics to disease management, Cell Mol Immunol, 19, 660, 10.1038/s41423-022-00858-1 · DOI
  124. Augsburger, 2019, Pharmacological characterization of the seven human NOX isoforms and their inhibitors, Redox Biol, 26, 10.1016/j.redox.2019.101272 · DOI
  125. Tarafdar, 2018, The role of NADPH oxidases and oxidative stress in neurodegenerative disorders, Int J Mol Sci, 19, 3824, 10.3390/ijms19123824 · DOI · Paper page
  126. Castro, 2021, Stress-induced reactive oxygen species compartmentalization, perception and signalling, Nat Plants, 7, 403, 10.1038/s41477-021-00887-0 · DOI
  127. El-Benna, 2008, Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane, Semin Immunopathol, 30, 279, 10.1007/s00281-008-0118-3 · DOI
  128. Ford, 2020, NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors, Cancer Res, 80, 1846, 10.1158/0008-5472.CAN-19-3158 · DOI · Paper page
  129. Block, 2012, Aiding and abetting roles of NOX oxidases in cellular transformation, Nat Rev Cancer, 12, 627, 10.1038/nrc3339 · DOI
  130. Xia, 2007, Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor, Cancer Res, 67, 10823, 10.1158/0008-5472.CAN-07-0783 · DOI
  131. Kleiboeker, 2022, Peroxisomal regulation of energy homeostasis: effect on obesity and related metabolic disorders, Mol Metab, 65, 10.1016/j.molmet.2022.101577 · DOI
  132. Sassetti, 2021, Small-molecule inhibitors of reactive oxygen species production, J Med Chem, 64, 5252, 10.1021/acs.jmedchem.0c01914 · DOI
  133. Sies, 2020, Reactive oxygen species (ROS) as pleiotropic physiological signalling agents, Nat Rev Mol Cell Bio, 21, 363, 10.1038/s41580-020-0230-3 · DOI · Paper page
  134. Azarova, 2023, Molecular genetics of abnormal redox homeostasis in type 2 diabetes mellitus, Int J Mol Sci, 24, 4738, 10.3390/ijms24054738 · DOI
  135. Jo, 2020, Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases, Exp Mol Med, 52, 1486, 10.1038/s12276-020-00503-9 · DOI
  136. Rashdan, 2020, Hydrogen peroxide in the ER: a tale of triage, Redox Biol, 28, 10.1016/j.redox.2019.101358 · DOI
  137. Bassot, 2023, The endoplasmic reticulum kinase PERK interacts with the oxidoreductase ERO1 to metabolically adapt mitochondria, Cell Rep, 42, 10.1016/j.celrep.2022.111899 · DOI
  138. Zito, 2015, ERO1: a protein disulfide oxidase and H2O2 producer, Free Radic Bio Med, 83, 299, 10.1016/j.freeradbiomed.2015.01.011 · DOI
  139. Roscoe, 2020, Pathways for sensing and responding to hydrogen peroxide at the endoplasmic reticulum, Cells, 9, 2314, 10.3390/cells9102314 · DOI
  140. Leung, 2013, Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells, Breast Cancer Res, 15, R107, 10.1186/bcr3574 · DOI
  141. Bhattarai, 2021, The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling, Exp Mol Med, 53, 151, 10.1038/s12276-021-00560-8 · DOI
  142. Hetz, 2020, Mechanisms, regulation and functions of the unfolded protein response, Nat Rev Mol Cell Bio, 21, 421, 10.1038/s41580-020-0250-z · DOI · Paper page
  143. Jena, 2021, The benzene metabolite p-benzoquinone inhibits the catalytic activity of bovine liver catalase: a biophysical study, Int J Biol Macromol, 167, 871, 10.1016/j.ijbiomac.2020.11.044 · DOI
  144. Pei, 2023, Research progress of glutathione peroxidase family (GPX) in redoxidation, Front Pharmacol, 14, 10.3389/fphar.2023.1147414 · DOI
  145. Sachdev, 2021, Abiotic stress and reactive oxygen species: generation, signaling, and defense mechanisms, Antioxidants, 10, 277, 10.3390/antiox10020277 · DOI
  146. Ferreira, 2023, The mammalian peroxisomal membrane is permeable to both GSH and GSSG–implications for intraperoxisomal redox homeostasis, Redox Biol, 63, 10.1016/j.redox.2023.102764 · DOI
  147. Wang, 2020, Sexual dimorphism in glutathione metabolism and glutathione-dependent responses, Redox Biol, 31, 10.1016/j.redox.2019.101410 · DOI
  148. Razi, 2021, Drought stress-induced physiological mechanisms, signaling pathways and molecular response of chloroplasts in common vegetable crops, Crit Rev Biotechnol, 41, 669, 10.1080/07388551.2021.1874280 · DOI
  149. Ansari, 2020, Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols, Biomed Pharmacother, 129, 10.1016/j.biopha.2020.110452 · DOI
  150. Halliwell, 2024, Understanding mechanisms of antioxidant action in health and disease, Nat Rev Mol Cell Bio, 25, 13, 10.1038/s41580-023-00645-4 · DOI
  151. Forman, 2021, Targeting oxidative stress in disease: promise and limitations of antioxidant therapy, Nat Rev Drug Discov, 20, 689, 10.1038/s41573-021-00233-1 · DOI · Paper page
  152. Galano, 2018, Melatonin and its metabolites vs oxidative stress: from individual actions to collective protection, J Pineal Res, 65, 10.1111/jpi.12514 · DOI
  153. Wang, 2019, Evolving concepts in the pathogenesis of uraemic cardiomyopathy, Nat Rev Nephrol, 15, 159, 10.1038/s41581-018-0101-8 · DOI
  154. Kang, 2020, Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications, Redox Biol, 37, 10.1016/j.redox.2020.101799 · DOI
  155. Rashdan, 2020, S-glutathionylation, friend or foe in cardiovascular health and disease, Redox Biol, 37, 10.1016/j.redox.2020.101693 · DOI
  156. Münzel, 2017, Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series, J Am Coll Cardiol, 70, 212, 10.1016/j.jacc.2017.05.035 · DOI
  157. Bai, 2022, Oxidative stress: the core pathogenesis and mechanism of alzheimer's disease, Ageing Res Rev, 77, 10.1016/j.arr.2022.101619 · DOI · Paper page
  158. Gong, 2020, DAMP-sensing receptors in sterile inflammation and inflammatory diseases, Nat Rev Immunol, 20, 95, 10.1038/s41577-019-0215-7 · DOI · Paper page
  159. Thakur, 2019, Connections between metabolism and epigenetics in cancers, Semin Cancer Biol, 57, 52, 10.1016/j.semcancer.2019.06.006 · DOI
  160. Paul, 2022, Tumor glycolysis, an essential sweet tooth of tumor cells, Semin Cancer Biol, 86, 1216, 10.1016/j.semcancer.2022.09.007 · DOI · Paper page
  161. Moloney, 2018, ROS signalling in the biology of cancer, Semin Cell Dev Biol, 80, 50, 10.1016/j.semcdb.2017.05.023 · DOI
  162. Prasad, 2017, Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals, Cancer Lett, 387, 95, 10.1016/j.canlet.2016.03.042 · DOI
  163. Arfin, 2021, Oxidative stress in cancer cell metabolism, Antioxidants, 10, 642, 10.3390/antiox10050642 · DOI
  164. Raimondi, 2020, Oncogenic pathways and the electron transport chain: a dangeROS liaison, Br J Cancer, 122, 168, 10.1038/s41416-019-0651-y · DOI
  165. Corn, 2020, Lipids in the tumor microenvironment: from cancer progression to treatment, Prog Lipid Res, 80, 10.1016/j.plipres.2020.101055 · DOI
  166. Yin, 2024, ALKBH5 mediates silica particles-induced pulmonary inflammation through increased m6A modification of slamf7 and autophagy dysfunction, J Hazard, 462
  167. Taniguchi, 2018, NF-κB, inflammation, immunity and cancer: coming of age, Nat Rev Immunol, 18, 309, 10.1038/nri.2017.142 · DOI · Paper page
  168. Jere, 2019, Role of the PI3K/AKT (mTOR and GSK3β) signalling pathway and photobiomodulation in diabetic wound healing, Cytokine Growth Factor Rev, 50, 52, 10.1016/j.cytogfr.2019.03.001 · DOI
  169. Saikolappan, 2019, Reactive oxygen species and cancer: a complex interaction, Cancer Lett, 452, 132, 10.1016/j.canlet.2019.03.020 · DOI
  170. Liu, 2022, The complexity of P53-mediated metabolic regulation in tumor suppression, Semin Cancer Biol, 85, 4, 10.1016/j.semcancer.2021.03.010 · DOI
  171. Xing, 2022, Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/P53 pathway, Autophagy, 18, 1932, 10.1080/15548627.2021.2008752 · DOI
  172. Ong, 2018, Role of SIRTUIN1-P53 regulatory axis in aging, cancer and cellular reprogramming, Ageing Res Rev, 43, 64, 10.1016/j.arr.2018.02.004 · DOI
  173. Wang, 2021, The double-edged roles of ROS in cancer prevention and therapy, Theranostics, 11, 4839, 10.7150/thno.56747 · DOI
  174. Jeggo, 2016, DNA repair, genome stability and cancer: a historical perspective, Nat Rev Cancer, 16, 35, 10.1038/nrc.2015.4 · DOI
  175. Huang, 2021, DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy, Signal Transduct Targeted Ther, 6, 254, 10.1038/s41392-021-00648-7 · DOI
  176. Bieging, 2014, Unravelling mechanisms of P53-mediated tumour suppression, Nat Rev Cancer, 14, 359, 10.1038/nrc3711 · DOI
  177. Rolfs, 2015, NRF2 activation promotes keratinocyte survival during early skin carcinogenesis via metabolic alterations, Cancer Res, 75, 4817, 10.1158/0008-5472.CAN-15-0614 · DOI
  178. Camiña, 2022, Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer, Br J Cancer, 126, 1244, 10.1038/s41416-021-01642-0 · DOI
  179. Jiang, 2023, Targeting incRNA DDIT4-AS1 sensitizes triple negative breast cancer to chemotherapy via suppressing of autophagy, Adv Sci, 10, 10.1002/advs.202207257 · DOI
  180. Lin, 2021, Pharmacological basis and new insights of deguelin concerning its anticancer effects, Pharmacol Res, 174, 10.1016/j.phrs.2021.105935 · DOI
  181. Yang, 2017, Tumor-associated macrophages: from basic research to clinical application, J Hematol Oncol, 10, 58, 10.1186/s13045-017-0430-2 · DOI · Paper page
  182. Li, 2021, Enhancing antibody-dependent cellular phagocytosis by re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes, Biomaterials, 268, 10.1016/j.biomaterials.2020.120601 · DOI
  183. Kennel, 2021, Immune cell-produced ROS and their impact on tumor growth and metastasis, Redox Biol, 42, 10.1016/j.redox.2021.101891 · DOI
  184. Massagué, 2021, Metastasis-initiating cells and ecosystems, Cancer Discov, 11, 971, 10.1158/2159-8290.CD-21-0010 · DOI · Paper page
  185. Hill, 2020, Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer, Semin Cancer Biol, 60, 202, 10.1016/j.semcancer.2019.07.028 · DOI
  186. De Visser, 2023, The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth, Cancer Cell, 41, 374, 10.1016/j.ccell.2023.02.016 · DOI · Paper page
  187. Padmanaban, 2019, E-cadherin is required for metastasis in multiple models of breast cancer, Nature, 573, 439, 10.1038/s41586-019-1526-3 · DOI
  188. Mao, 2014, Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells, J Intern Med, 276, 154, 10.1111/joim.12229 · DOI
  189. Morry, 2017, Oxidative stress in cancer and fibrosis: opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles, Redox Biol, 11, 240, 10.1016/j.redox.2016.12.011 · DOI
  190. Mori, 2019, A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells, FEBS J, 286, 459, 10.1111/febs.14671 · DOI
  191. Zhang, 2022, Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals, Cell Death Discov, 8, 500, 10.1038/s41420-022-01291-z · DOI
  192. Yazaki, 2021, ROS-NRF2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of notch signaling, Eur J Cell Biol, 100, 10.1016/j.ejcb.2021.151181 · DOI
  193. Datta, 2023, Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity, Autophagy, 19, 966, 10.1080/15548627.2022.2109286 · DOI
  194. Panieri, 2016, ROS homeostasis and metabolism: a dangerous liaison in cancer cells, Cell Death Dis, 7, e2253, 10.1038/cddis.2016.105 · DOI
  195. Ding, 2021, Glutathione-mediated nanomedicines for cancer diagnosis and therapy, Chem Eng J, 426, 10.1016/j.cej.2021.128880 · DOI
  196. Wu, 2024, Nanomaterials-induced redox imbalance: challenged and opportunities for nanomaterials in cancer therapy, Adv Sci, 11
  197. Steinbrenner, 2013, Toward understanding success and failures in the use of selenium for cancer prevention, Antioxid Redox Sign, 19, 181, 10.1089/ars.2013.5246 · DOI
  198. Zhang, 2022, Platinum-based drugs for cancer therapy and anti-tumor strategies, Theranostics, 12, 2115, 10.7150/thno.69424 · DOI
  199. Liu, 2019, Antioxidative nanomaterials and biomedical applications, Nano Today, 27, 146, 10.1016/j.nantod.2019.05.008 · DOI
  200. Chaiswing, 2018, Redox paradox: a novel approach to therapeutics-resistant cancer, Antioxid Redox Sign, 29, 1237, 10.1089/ars.2017.7485 · DOI

200 of 301 shown

Cited by

Sorted by citations

See all 153

Metadata

Authors
Hu, D., Li, Y., Li, R., Wang, M., Zhou, K., He, C., Wei, Q., & Qian, Z.
Venue
Acta Pharmaceutica Sinica B
Publisher
Elsevier BV
Published
2024-12
Volume
14
Issue
12
Pages
5106-5131
ISSN
2211-3835
DOI
10.1016/j.apsb.2024.10.015
PMC
PMC11725102
Cited by
153
References
25
Language
en
Licence
Funders
  • Natural Science Foundation of Sichuan Province (2022NSFSC1282)
  • Sichuan University
  • National Natural Science Foundation of China (U21A20417, 32001003, 31930067)
  • West China Hospital of Sichuan University (ZYGD18002)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review